Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Bluebird Bio IncBLUE-5.0628.65-263.06-1.07-186.70%-38.74%27.04$6.99$22.932,184$7.85

Detail of Bluebird Bio Inc

CEO
Mr. Andrew Obenshain
Employees
375
Industry
Biotechnology
Sector
Healthcare
Market cap
$2B

Company details

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$53.12M
Cost of goods (CoG)
-$76.22M
Gross profit (GP)
-$23.10M
Operating expense (OE)
-$290.76M
Research and development (R&D)
-$107.18M
General and administrative (G&A)
-$183.58M
Operating income (OI)
-$313.86M
Other income expense (OIE)
-$36.74M
Pretax income (PI)
-$300.60M
Tax (TAX)
$83,000.00
Net income (NI)
-$300.52M
Bluebird Bio Inc
BLUE • XNGS • US
$7.85
+6.68 (575.86%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$1.55
Margin profit
-13.66%
52 week low
$0.2946
52 week high
$10.244
50-day simple moving average
$8.17
200-day simple moving average
$6.99
Percent held by insiders
0.63%
Percent held by institutions
43.69%
Dividend yield
0.00%

Change of shares

Cash vs Debt

  • Cash

  • Debt

Insider Trading

  • Sell

Comparison of selected companies

  • Bluebird Bio Inc

%
Price change
BLUE +632.71%
eps change
BLUE 0.00%